These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34595578)

  • 1. Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability.
    Sumaila M; Marimuthu T; Kumar P; Choonara YE
    AAPS PharmSciTech; 2021 Sep; 22(7):242. PubMed ID: 34595578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on polymer-lipid hybrid systems for improving oral drug delivery.
    Maghrebi S; Prestidge CA; Joyce P
    Expert Opin Drug Deliv; 2019 May; 16(5):507-524. PubMed ID: 30957577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
    Suchaoin W; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
    Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
    Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
    Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches in lipid-based nanocarriers for oral drug delivery.
    Plaza-Oliver M; Santander-Ortega MJ; Lozano MV
    Drug Deliv Transl Res; 2021 Apr; 11(2):471-497. PubMed ID: 33528830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bioavailability: issues and solutions via nanoformulations.
    Pathak K; Raghuvanshi S
    Clin Pharmacokinet; 2015 Apr; 54(4):325-57. PubMed ID: 25666353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems.
    Mehandole A; Walke N; Mahajan S; Aalhate M; Maji I; Gupta U; Mehra NK; Singh PK
    AAPS PharmSciTech; 2023 Jan; 24(1):50. PubMed ID: 36703085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
    Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
    Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
    Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
    Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
    Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
    J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.